Structure-based discovery of selective serotonin 5-HT1B receptor Ligands

Structure

Volumn 22, Issue 8, 2014, Pages 1140-1151

  Rodríguez, David ^a,b   Brea, José ^c   Loza, María Isabel ^c   Carlsson, Jens ^a,b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b Linköping University   (Sweden)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; SEROTONIN 1B RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN; TRYPTAMINE; CYCLIC AMP; SEROTONIN 1 AGONIST;

ARTICLE; BINDING ASSAY; CRYSTAL STRUCTURE; HUMAN; MOLECULAR DOCKING; MOLECULE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; METABOLISM; PROCEDURES; PROTEIN CONFORMATION;

CYCLIC AMP; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; SEROTONIN 5-HT1 RECEPTOR AGONISTS;

EID: 84905730759     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2014.05.017     Document Type: Article

References (60)

1. J.A. Ballesteros, and H. Weinstein Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors Methods Neurosci. 25 1995 366 428
2. M. Berger, J.A. Gray, and B.L. Roth The expanded biology of serotonin Annu. Rev. Med. 60 2009 355 366
3. J. Besnard, G.F. Ruda, V. Setola, K. Abecassis, R.M. Rodriguiz, X.P. Huang, S. Norval, M.F. Sassano, A.I. Shin, and L.A. Webster et al. Automated design of ligands to polypharmacological profiles Nature 492 2012 215 220
4. C. Bissantz, C. Schalon, W. Guba, and M. Stahl Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods Proteins Struct. Funct. Bioinf. 61 2005 938 952
5. J. Carlsson, L. Yoo, Z.-G. Gao, J.J. Irwin, B.K. Shoichet, and K.A. Jacobson Structure-based discovery of A2A adenosine receptor ligands J. Med. Chem. 53 2010 3748 3755
6. J. Carlsson, R.G. Coleman, V. Setola, J.J. Irwin, H. Fan, A. Schlessinger, A. Sali, B.L. Roth, and B.K. Shoichet Ligand discovery from a dopamine D3 receptor homology model and crystal structure Nat. Chem. Biol. 7 2011 769 778
7. C.N. Cavasotto, A.J. Orry, N.J. Murgolo, M.F. Czarniecki, S.A. Kocsi, B.E. Hawes, K.A. O'Neill, H. Hine, M.S. Burton, and J.H. Voigt et al. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening J. Med. Chem. 51 2008 581 588
8. ChemAxon (2012). JChem 5.11.4 (http://www.chemaxon.com).
9. E.Y.T. Chien, W. Liu, Q. Zhao, V. Katritch, G.W. Han, M.A. Hanson, L. Shi, A.H. Newman, J.A. Javitch, V. Cherezov, and R.C. Stevens Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 330 2010 1091 1095
10. C. de Graaf, and D. Rognan Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor J. Med. Chem. 51 2008 4978 4985
11. C. de Graaf, N. Foata, O. Engkvist, and D. Rognan Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening Proteins Struct. Funct. Bioinf. 71 2008 599 620
12. C. de Graaf, A.J. Kooistra, H.F. Vischer, V. Katritch, M. Kuijer, M. Shiroishi, S. Iwata, T. Shimamura, R.C. Stevens, I.J. de Esch, and R. Leurs Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor J. Med. Chem. 54 2011 8195 8206
13. A. Evers, and T. Klabunde Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor J. Med. Chem. 48 2005 1088 1097
14. A. Gaulton, L.J. Bellis, A.P. Bento, J. Chambers, M. Davies, A. Hersey, Y. Light, S. McGlinchey, D. Michalovich, B. Al-Lazikani, and J.P. Overington ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 40 2012 D1100 D1107
15. K.M. Giacomini, R.M. Krauss, D.M. Roden, M. Eichelbaum, M.R. Hayden, and Y. Nakamura When good drugs go bad Nature 446 2007 975 977
16. J. Hannon, and D. Hoyer Molecular biology of 5-HT receptors Behav. Brain Res. 195 2008 198 213
17. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, and P.P. Humphrey International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) Pharmacol. Rev. 46 1994 157 203
18. J.J. Irwin, B.K. Shoichet, M.M. Mysinger, N. Huang, F. Colizzi, P. Wassam, and Y. Cao Automated docking screens: a feasibility study J. Med. Chem. 52 2009 5712 5720
19. J.J. Irwin, T. Sterling, M.M. Mysinger, E.S. Bolstad, and R.G. Coleman ZINC: a free tool to discover chemistry for biology J. Chem. Inf. Model. 52 2012 1757 1768
20. V. Katritch, K.A. Reynolds, V. Cherezov, M.A. Hanson, C.B. Roth, M. Yeager, and R. Abagyan Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes J. Mol. Recognit. 22 2009 307 318
21. V. Katritch, V.P. Jaakola, J.R. Lane, J. Lin, A.P. Ijzerman, M. Yeager, I. Kufareva, R.C. Stevens, and R. Abagyan Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists J. Med. Chem. 53 2010 1799 1809
22. V. Katritch, I. Kufareva, and R. Abagyan Structure based prediction of subtype-selectivity for adenosine receptor antagonists Neuropharmacology 60 2011 108 115
23. V. Katritch, V. Cherezov, and R.C. Stevens Structure-function of the G protein-coupled receptor superfamily Annu. Rev. Pharmacol. Toxicol. 53 2013 531 556
24. M.J. Keiser, V. Setola, J.J. Irwin, C. Laggner, A.I. Abbas, S.J. Hufeisen, N.H. Jensen, M.B. Kuijer, R.C. Matos, and T.B. Tran et al. Predicting new molecular targets for known drugs Nature 462 2009 175 181
25. P. Kolb, D.M. Rosenbaum, J.J. Irwin, J.J. Fung, B.K. Kobilka, and B.K. Shoichet Structure-based discovery of beta2-adrenergic receptor ligands Proc. Natl. Acad. Sci. U S A 106 2009 6843 6848
26. P. Kolb, K. Phan, Z.G. Gao, A.C. Marko, A. Sali, and K.A. Jacobson Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists PLoS ONE 7 2012 e49910
27. A.J. Kooistra, L. Roumen, R. Leurs, I.J. de Esch, and C. de Graaf From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands Methods Enzymol. 522 2013 279 336
28. A.C. Kruse, D.R. Weiss, M. Rossi, J. Hu, K. Hu, K. Eitel, P. Gmeiner, J. Wess, B.K. Kobilka, and B.K. Shoichet Muscarinic receptors as model targets and antitargets for structure-based ligand discovery Mol. Pharmacol. 84 2013 528 540
29. I. Kufareva, M. Rueda, V. Katritch, R.C. Stevens, R. Abagyan GPCR Dock 2010 Participants Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment Structure 19 2011 1108 1126
30. I. Kufareva, V. Katritch, R.C. Stevens, and Abagyan Advances in GPCR modeling evaluated by the GPCR dock 2013 assessment: meeting new challenges Structure 22 2014 1120 1139 this issue
31. J.R. Lane, P. Chubukov, W. Liu, M. Canals, V. Cherezov, R. Abagyan, R.C. Stevens, and V. Katritch Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors Mol. Pharmacol. 84 2013 794 807
32. C.J. Langmead, S.P. Andrews, M. Congreve, J.C. Errey, E. Hurrell, F.H. Marshall, J.S. Mason, C.M. Richardson, N. Robertson, A. Zhukov, and M. Weir Identification of novel adenosine A(2A) receptor antagonists by virtual screening J. Med. Chem. 55 2012 1904 1909
33. W. Liu, D. Wacker, C. Gati, G.W. Han, D. James, D. Wang, G. Nelson, U. Weierstall, V. Katritch, and A. Barty et al. Serial femtosecond crystallography of G protein-coupled receptors Science 342 2013 1521 1524
34. D.M. Lorber, and B.K. Shoichet Hierarchical docking of databases of multiple ligand conformations Curr. Top. Med. Chem. 5 2005 739 749
35. M. Michino, E. Abola, C.L. Brooks 3rd, J.S. Dixon, J. Moult, R.C. Stevens GPCR Dock 2008 participants Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 Nat. Rev. Drug Discov. 8 2009 455 463
36. M.M. Mysinger, and B.K. Shoichet Rapid context-dependent ligand desolvation in molecular docking J. Chem. Inf. Model. 50 2010 1561 1573
37. M.M. Mysinger, D.R. Weiss, J.J. Ziarek, S. Gravel, A.K. Doak, J. Karpiak, N. Heveker, B.K. Shoichet, and B.F. Volkman Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4 Proc. Natl. Acad. Sci. U S A 109 2012 5517 5522
38. A. Negri, M.L. Rives, M.J. Caspers, T.E. Prisinzano, J.A. Javitch, and M. Filizola Discovery of a novel selective kappa-opioid receptor agonist using crystal structure-based virtual screening J. Chem. Inf. Model. 53 2013 521 526
39. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years J. Nat. Prod. 70 2007 461 477
40. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat. Rev. Drug Discov. 5 2006 993 996
41. S.G. Rasmussen, H.J. Choi, J.J. Fung, E. Pardon, P. Casarosa, P.S. Chae, B.T. Devree, D.M. Rosenbaum, F.S. Thian, and T.S. Kobilka et al. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor Nature 469 2011 175 180
42. D. Rodríguez, and H. Gutiérrez-de-Terán Computational approaches for ligand discovery and design in class-A G protein- coupled receptors Curr. Pharm. Des. 19 2013 2216 2236
43. D. Rodríguez, A. Ranganathan, and J. Carlsson Strategies for improved modeling of GPCR-drug complexes: blind predictions of serotonin receptors bound to ergotamine J. Chem. Inf. Model 2014 10.1021/ci5002235
44. B.L. Roth, E. Lopez, S. Patel, and W.K. Kroeze The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches? Neuroscientist 6 2000 252 262
45. A. Sali, and T.L. Blundell Comparative protein modelling by satisfaction of spatial restraints J. Mol. Biol. 234 1993 779 815
46. P. Schmidtke, V. Le Guilloux, J. Maupetit, and P. Tufféry fpocket: online tools for protein ensemble pocket detection and tracking Nucleic Acids Res. 38 2010 W582 W589
47. J. Selent, L. López, F. Sanz, and M. Pastor Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta2 adrenergic receptor template ChemMedChem 3 2008 1194 1198
48. J. Selent, A. Bauer-Mehren, L. López, M.I. Loza, F. Sanz, and M. Pastor A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints Mol. Pharmacol. 77 2010 149 158
49. M.Y. Shen, and A. Sali Statistical potential for assessment and prediction of protein structures Protein Sci. 15 2006 2507 2524
50. B.K. Shoichet, and B.K. Kobilka Structure-based drug screening for G-protein-coupled receptors Trends Pharmacol. Sci. 33 2012 268 272
51. F. Sirci, E.P. Istyastono, H.F. Vischer, A.J. Kooistra, S. Nijmeijer, M. Kuijer, M. Wijtmans, R. Mannhold, R. Leurs, I.J.P. de Esch, and C. de Graaf Virtual fragment screening: discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints J. Chem. Inf. Model. 52 2012 3308 3324
52. The Sumatriptan Cluster Headache Study Group Treatment of acute cluster headache with sumatriptan N. Engl. J. Med. 325 1991 322 326
53. J. Varady, X. Wu, X. Fang, J. Min, Z. Hu, B. Levant, and S. Wang Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach J. Med. Chem. 46 2003 4377 4392
54. A.J. Venkatakrishnan, X. Deupi, G. Lebon, C.G. Tate, G.F. Schertler, and M.M. Babu Molecular signatures of G-protein-coupled receptors Nature 494 2013 185 194
55. D. Wacker, C. Wang, V. Katritch, G.W. Han, X.P. Huang, E. Vardy, J.D. McCorvy, Y. Jiang, M. Chu, and F.Y. Siu et al. Structural features for functional selectivity at serotonin receptors Science 340 2013 615 619
56. C. Wang, Y. Jiang, J. Ma, H. Wu, D. Wacker, V. Katritch, G.W. Han, W. Liu, X.P. Huang, and E. Vardy et al. Structural basis for molecular recognition at serotonin receptors Science 340 2013 610 614
57. T. Warne, R. Moukhametzianov, J.G. Baker, R. Nehmé, P.C. Edwards, A.G. Leslie, G.F. Schertler, and C.G. Tate The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor Nature 469 2011 241 244
58. T. Warne, P.C. Edwards, A.G. Leslie, and C.G. Tate Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol Structure 20 2012 841 849
59. M. Wawer, and J. Bajorath Similarity-potency trees: a method to search for SAR information in compound data sets and derive SAR rules J. Chem. Inf. Model. 50 2010 1395 1409
60. D.R. Weiss, S. Ahn, M.F. Sassano, A. Kleist, X. Zhu, R. Strachan, B.L. Roth, R.J. Lefkowitz, and B.K. Shoichet Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor ACS Chem. Biol. 8 2013 1018 1026